GE Healthcare Zeroes In On Cath Lab With Partnering Strategy
This article was originally published in The Gray Sheet
Executive Summary
GE Healthcare is embarking on a series of strategic partnerships with device firms to increase its footprint in coronary catheterization labs
You may also be interested in...
Volcano Ready To Erupt? Vascular Imaging Start-Up Lures Big-Time Partners
Ultrasound catheter firm Volcano Corp. only went public in June, but it has already attracted noticeable interest from the top players in the device industry
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.